Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations

Market news

17 April 2018

Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations

Johnson & Johnson (JNJ) reported Q1 FY 2018 earnings of $2.06 per share (versus $1.83 in Q1 FY 2017), beating analysts' consensus estimate of $2.00.

The company's quarterly revenues amounted to $20.009 bln (+12.6% y/y), beating analysts' consensus estimate of $19.497 bln.

The company also issued guidance for FY 2018, projecting EPS of $8.00-8.20 (versus analysts' consensus estimate of $8.10) at revenues of $81.0-81.8 bln (versus analysts' consensus estimate of $81.18 bln and its prior guidance of $80.6-81.4 bln).

JNJ rose to $133.25 (+1.13%) in pre-market trading.

Company News: Goldman Sachs (GS) quarterly results beat analysts’ forecasts

Company News: UnitedHealth (UNH) quarterly earnings beat analysts’ estimate

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.